Greater Manchester Police has issued a full apology statement to Andrew Malkinson, a man who was jailed for 17 years for a rape he did not commit.
Today, Malkinson’s conviction was overturned after a 20-year-long fight.
The 57-year-old had always maintained that he was innocent of the attack committed in Salford in 2004.
His case was referred to the Court of Appeal in January after new evidence pointed to another potential suspect, and overturned today by Lord Justice Holroyd.
Speaking outside the court, Mr Malkinson said: “People convicted of rape are the lowest of the low. I did not commit the crime, but I was treated as if I did. I spent 17 years on my guard against every threat.
ADVERTISEMENT
“Seventeen years counting down the minutes to lock up, so I could be behind my door and safe from other prisoners, but not safe from my own mind, imagining I would die there, perhaps murdered.
“But somehow I lived.”
ADVERTISEMENT
Greater Manchester Police said that they were ‘truly sorry’ to Mr Malkinson, adding an apology to the victim of the crime.
In a statement, the force said: “In this case, the judicial process failed, and the wrong man was convicted.”
GMP’s full statement to Andrew Malkinson, from Assistant Chief Constable Sarah Jackson
Andrew Malkinson’s mugshot and, right, the e-fit of the suspect. Credit: GMP
“We are truly sorry to Mr Malkinson that he is the victim of such a grave miscarriage of justice, in being convicted of a crime he did not commit and serving a 17-year custodial sentence. Whilst we hope this outcome gives him a long overdue sense of justice, we acknowledge that it does not return the years he has lost. I have offered to meet with him to personally deliver this apology.
ADVERTISEMENT
“We are also profoundly sorry to the victim of this crime, who not only suffered an horrific trauma 20 years ago, but also relived the experience during a criminal trial, and now may endure additional harm caused by learning that the true offender has not yet been brought to justice. We are absolutely committed to following all new lines of enquiry to ensure the right person is held accountable for harming her.
“Whilst this case tragically led to the wrong person being convicted, these instances are thankfully very rare. Following an appeal heard by the Court of Appeal in 2006, and two reviews by the Criminal Cases Review Commission (CCRC), a full and thorough review of the original investigation was carried out by GMP. The force has and will continue to fully cooperate with any further reviews of this case and action will be taken if it is found that anything could have been done differently.
“In the vast majority of cases, the processes our officers follow lead to a case being presented to the CPS whereby the suspect and evidence collected were relevant to the crime committed. The evidence presented by GMP and the CPS at court between 2003-2004 was subject to a full criminal trial before a jury, who ultimately reached the final guilty verdict. Sadly, in this case it is now clear that the wrong person was convicted.
“Due to new forensic evidence, following developments in forensic technologies, there is a live criminal investigation in which a suspect remains on bail. We cannot comment further on that matter at this time.
“We are sorry that in this case, the judicial process failed, and the wrong man was convicted. We are determined to work with our colleagues in the CPS to ensure all new evidence is fully examined and that the person truly responsible is convicted and the victim of this horrific crime receives the justice deserved.”
A gentle and patient man of superhuman fortitude and forbearance. It’s been the honour of my career to represent Andrew Malkinson. @we_are_APPEAL have been dogged and relentless in the pursuit of justice and my leader and pupil master @edwardhenry1 brought his best to the case. pic.twitter.com/xHL2fAUE9q
The simple hack that can save healthcare workers and teachers money on their holidays
Danny Jones
With cost-of-living pressure ever-present in the background of most everyday lives, finding some spare pennies for a getaway feels more difficult than ever, and if there’s anyone who deserves discounts on a holiday, it’s healthcare workers.
That’s why, when we became aware of the simple hack that can save those working in healthcare services money on holidays, we thought we’d help spread the word.
We’re sure lots of you working within the sector already know plenty about this booking strategy, but for anyone who doesn’t, how do you fancy saving up to half a grand on your next jolly?
In fact, even those working in education can cut their costs, too.
With searches for ‘holiday voucher code’ up by 73% on Google, and even the likes of TikTok seeing ‘money saving tips’ up by 45%, travel agency TUI have decided to team up with the Health Service Discounts platform for 2026.
Providing those who work for the NHS with a ‘Holidays for Heroes’ (HfH) access code on various popular peak-season trips, this exclusive discount can be added on top of all other seasonal TUI deals, including the company’s ‘First Choice’ package holidays.
With the HfH code alone guaranteeing workers an extra £100 off their bookings, play your cards right, and you could get up to £500 in total discounts overall.
How to access the healthcare ‘Holidays for Heroes’ deal
Separate from standard Blue Light card savings, here’s how it works, and don’t worry, it’s all very simple:
As mentioned, education workers can also benefit from similar money off, with an extra £50 per person through the TUI x Discounts for Teachers partnership, as well.
Ella Foden-Lynch, Partnerships Manager for TUI, said in a statement: “Getting away is absolutely vital for wellbeing, especially for those working in high-stress healthcare and education roles.
“With the cost-of-living crisis still putting a strain on household budgets, we know how hard it is to stretch your pay to cover a much-needed family break. By unlocking these exclusive TUI deals, we hope to give our key workers the realistic recovery time they deserve without the financial worry.”
So, for those of you healthcare heroes and teachers looking for a well-deserved break, we urge you to find an affordable holiday that suits you very soon. With cheaper airport pints also inbound later this year, here’s hoping you save even more spends for when you’re away.
New ‘cutting-edge’ cancer treatment to be rolled out on NHS from next week
Emily Sergeant
A new ‘cutting-edge’ cancer treatment is set to be rolled out on the NHS from next week.
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively – helping reduce side-effects and spare them 15 courses of treatment.
The highly targeted SABR (stereotactic ablative radiotherapy) delivers radiotherapy to the tumour from many different directions to help reduce the risk of cancer spreading or returning.
SABR has been proven to be effective at far fewer doses than conventional radiotherapy.
Standard radiotherapy can often be a major burden for patients and loved ones, due to the substantial treatment and travel time involved, but SABR is typically delivered in just five doses within a fortnight, compared to at least 20 doses with external beam radiotherapy.
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively, helping reduce side-effects and spare them 15 courses of treatment.
Around 17,500 men are diagnosed with low or intermediate risk prostate cancer in England each year and could be offered the option of SABR radiotherapy.
It is expected that the cutting-edge technique for localised prostate cancer will be offered at all 48 radiotherapy providers across England in the coming days – with the first centres making it available on the NHS from next week.
The roll-out could free up around 50,000 appointments for prostate cancer treatment each year, helping the NHS continue to bring down waiting times for patients.
NHS chief executive, Sir Jim Mackey, said the news will ‘transform’ treatment for thousands of men with localised prostate cancer.
“This cutting-edge approach will transform treatment for thousands of men with prostate cancer, helping the NHS provide far more powerful and convenient care to stop their cancer spreading,” Sir Mackey commented.
“Having been proven effective in keeping cancer under control, this technology will not only help reduce the risk of certain side effects but also the major ‘to-and-fro’ burden of hospital treatment, which can be really draining for so many patients and their families.”